Skip to main content
. 2016 Jan 20;11(2):254–261. doi: 10.2215/CJN.05760515

Table 4.

Spearman correlations (P values) between clinical and morphometric variables in 111 Pima Indians with type 2 diabetes mellitus

Characteristic GS, % VG, μm3 VvInt, % VvMes, % SV, μ2/μ3 TFS, μ2 GBM, nm E + M, No. Podo, No. FPW, nm PD, % Fen, %
Age, yr 0.40 (<0.001)a −0.27 (0.004)a 0.24 (0.01)a −0.01 (0.91) 0.02 (0.85) −0.14 (0.14) −0.19 (0.04)a −0.20 (0.03)a −0.21 (0.03)a 0.11 (0.26) 0.04 (0.70) 0.14 (0.15)
Diabetes duration, yr 0.31 (0.001)a −0.11 (0.27) 0.40 (<0.001)a 0.42 (<0.001)a −0.31 (0.001)a −0.37 (<0.001)a 0.24 (0.01)a 0.12 (0.19) −0.21 (0.03)a 0.166 (0.08) 0.13 (0.17) −0.22 (0.02)a
MAP, mmHg −0.01 (0.95) 0.21 (0.03)a 0.11 (0.26) 0.22 (0.02)a −0.13 (0.17) −0.03 (0.78) 0.24 (0.01)a 0.35 (<0.001)a 0.05 (0.57) 0.25 (0.01)a 0.09 (0.34) −0.17 (0.07)
BMI, kg/m2 0.05 (0.63) 0.08 (0.39) −0.18 (0.06) −0.23 (0.01)a 0.19 (0.05) 0.23 (0.02)a −0.28 (0.003)a −0.02 (0.81) 0.01 (0.92) −0.15 (0.12) −0.05 (0.59) −0.01 (0.92)
HbA1c, % −0.31 (0.001)a 0.26 (0.01)a 0.08 (0.42) 0.27 (0.004)a −0.16 (0.10) −0.02 (0.87) 0.34 (<0.001)a 0.29 (0.002) 0.06 (0.53) 0.17 (0.07) 0.07 (0.44) −0.19 (0.05)
ACR, mg/g 0.07 (0.44) 0.34 (<0.001)a 0.23 (0.01)a 0.54 (<0.001)a −0.49 (<0.001)a −0.23 (0.02)a 0.54 (<0.001)a 0.43 (<0.001)a −0.15 (0.11) 0.28 (0.003)a 0.12 (0.20) −0.43 (<0.001)a
GFR, ml/min −0.29 (0.002)a 0.34 (<0.001)a −0.29 (0.002)a −0.31 (<0.001)a 0.27 (0.004)a 0.46 (<0.001)a −0.10 (0.32) 0.11 (0.27) 0.26 (0.01)a −0.11 (0.25) −0.07 (0.46) 0.22 (0.02)a

GS, global sclerosis; VG, mean glomerular volume; VvInt, cortical interstitial fractional volume; VvMes, mesangial fractional volume; SV, glomerular filtration surface density; TFS, total filtration surface; GBM, glomerular basement membrane width; E + M, endothelial and mesangial cells per glomerulus; Podo, podocytes per glomerulus; FPW, foot process width; PD, podocyte detachment along glomerular basement membrane; Fen, fenestrated endothelial cells; MAP, mean arterial pressure; BMI, body mass index; HbA1c, hemoglobin A1c; ACR, albumin-to-creatinine ratio.

a

P values <0.05.

HHS Vulnerability Disclosure